|
Mar 13
|
Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note
|
|
Mar 13
|
Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?
|
|
Mar 13
|
How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma
|
|
Mar 13
|
Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today?
|
|
Mar 12
|
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
|
|
Mar 12
|
B. Riley sees two key positives in Viking manufacturing agreement
|
|
Mar 12
|
VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply
|
|
Mar 11
|
Viking strikes $150m deal to secure supply of obesity drug
|
|
Mar 11
|
Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.
|
|
Mar 11
|
Stellantis, Tesla, Viking Therapeutics: Market Minute
|
|
Mar 11
|
Viking Therapeutics closer to bringing its Ozempic competitor to market
|
|
Mar 11
|
Update: Viking Therapeutics Shares Fall After Manufacturing Deal With CordenPharma
|
|
Mar 11
|
H.C. Wainwright says Novo results support Viking obesity potential
|
|
Mar 11
|
Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?
|
|
Mar 11
|
Viking inks CordenPharma deal to boost obesity drug supply
|
|
Mar 11
|
Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735
|
|
Feb 28
|
1 Biotech Stock to Buy in 2025, and 1 to Avoid
|
|
Feb 28
|
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
|
|
Feb 26
|
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory
|
|
Feb 26
|
Is Viking Therapeutics a Buy Right Now?
|